Specifically, CXCL14 activates the CCR7/JAK2/STAT3 axis, leading to the upregulation of ERCC4 transcription, which promotes DNA damage repair in bladder cancer cells, thereby facilitating the development of chemoresistance. This evidence concerns the gene JAK2 and urinary bladder cancer.